Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

Sun, Yu, Campisi, Judith, Higano, Celestia, Beer, Tomasz M, Porter, Peggy, Coleman, Ilsa, True, Lawrence, Nelson, Peter S·2012·Nature Medicine

Cited by (791)

Items 501–600 of 791

  1. B‐cell performance in chemotherapy: Unravelling the mystery of B‐cell therapeutic potential
    Zizhuo Li, Anqi Lin, Zhifei Gao, Aimin Jiang, Minying Xiong, Jiapeng Song, Zaoqu Liu, Quan Cheng, Jian Zhang, Peng Luo · 2024 · Clinical and Translational Medicine
  2. Prostate Cancer Tumor Stroma: Responsibility in Tumor Biology, Diagnosis and Treatment
    Luis O. González, Noemí Eiró, María Fraile, Nana Béridze, Andres R. Escaf, Safwan Escaf, Jesús María Fernández Gómez, Francisco José Vizoso · 2022 · Cancers
  3. Trimethylamine N-oxide: role in cell senescence and age-related diseases
    Lin Zhang, Fang Yu, Jian Xia · 2022 · European Journal of Nutrition
  4. Stromal-derived MAOB promotes prostate cancer growth and progression
    Tianjie Pu, Jing Wang, Jing Wei, A Zeng, Jinglong Zhang, Jingrui Chen, Lijuan Yin, Jingjing Li, Tzu‐Ping Lin, Jonathan Melamed et al. · 2024 · Science Advances
  5. DNA Damage Induces a Secretory Program in the Quiescent TME that Fosters Adverse Cancer Phenotypes
    Luis Gomez-Sarosi, Yu Sun, Ilsa M. Coleman, Daniella Bianchi-Frias, Peter S. Nelson · 2017 · Molecular Cancer Research
  6. “Cytokine-Mediated tumor sensitization: mechanistic frameworks and therapeutic opportunities in cancer Immunotherapy”
    Mojtaba Aghaei, Seyed Sobhan Bahreiny, Amir Hossein Mahdizade, Ali Abbasi, AmirMohammad Magharati, Arshid Yousefi Avarvand · 2026 · Clinical and Experimental Medicine
  7. Cells of the tumor microenvironment speak the Wnt language.
    V. Katanaev, Alexey V Baldin, T. Denisenko, D. Silachev, Anna E. Ivanova, G. Sukhikh, Lee Jia, L. Ashrafyan · 2023 · Trends in Molecular Medicine
  8. Chemoresistant fibroblasts dictate neoadjuvant chemotherapeutic response of head and neck cancer via TGFα-EGFR paracrine signaling
    Liangping Su, Sangqing Wu, Cheng Huang, Xianhua Zhuo, Jiali Chen, Xue Jiang, Xiangzhan Kong, Cui Lv, Qiuping Xu, Ping Han et al. · 2023 · npj Precision Oncology
  9. In vivo detection of drug-induced apoptosis in tumors using Raman spectroscopy
    Oliver H. Jonas, Jeon Woong Kang, Surya Pratap Singh, Alex Lammers, Freddy T. Nguyen, Ramachandra Rao Dasari, Peter T. C. So, Róbert Langer, Michael J. Cima · 2018 · The Analyst
  10. Senescence and castration resistance in prostate cancer: A review of experimental evidence and clinical implications
    Valerie J. Carpenter, Bhaumik B. Patel, Riccardo Autorino B, Steven Christopher Smith, David A. Gewirtz, Tareq Saleh · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  11. Transglutaminases: future perspectives
    Simone Beninati, Francesco Facchiano, Mauro Piacentini · 2012 · Amino Acids
  12. One‐Two Punch Therapy for the Treatment of T‐Cell Malignancies Involving p53‐Dependent Cellular Senescence
    Yingjie Qing, Hui Li, Yunzi Zhao, Po Hu, Xiangyuan Wang, Xiaoxuan Yu, Mengyuan Zhu, Hongzheng Wang, Zhanyu Wang, Qinglong Guo et al. · 2021 · Oxidative Medicine and Cellular Longevity
  13. Cellular Senescence in Normal Mammary Gland and Breast Cancer. Implications for Cancer Therapy
    Chaido Sirinian, Stavros Peroukidis, Katharina Kriegsmann, Dimitrios I. Chaniotis, Angelos K. Koutras, Mark Kriegsmann, Anastasios D. Papanastasiou · 2022 · Genes
  14. Nichotherapy for stem cells: There goes the neighborhood
    Jean-Pierre Lévesque, Ingrid G. Winkler, John E.J. Rasko · 2012 · BioEssays
  15. The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stress
    Yanan Liu, Juanjuan Feng, Kun Yuan, Zhengzhen Wu, Longmiao Hu, Yue Lu, Kun Li, Jiawei Guo, Jing Chen, Chengbin Ma et al. · 2022 · eLife
  16. Adjuvant Therapy Reduces the Benefit of Palliative Treatment in Disseminated Breast Cancer - Own Findings and Review of the Literature
    Ulrich Richard Kleeberg, Michael K. Fink, Hans-Werner Tessen, Alice Nennecke, Stefan Hentschel, Stefan Bartels · 2013 · Oncology Research and Treatment
  17. Regeneration of sciatic nerves by transplanted microvesicles of human neural stem cells derived from embryonic stem cells
    Xiang 'Anthony' Chen, Kai Ye, Jiahong Yu, Jianyi Gao, Lei Zhang, Xianyan Ji, Tianyan Chen, Hui Wang, Yao Dai, Bin Tang et al. · 2020 · Cell and Tissue Banking
  18. Prostate cancer stem cell dynamics in the evolution of drug resistance
    Xiaoyu Zhang, Xiaoqing Zhang, Xinpei Deng, Jingna Cao, Qing Bao, Huan Wang, Dong Chen, Hailin Tang · 2025 · International Journal of Surgery
  19. Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks
    Kelvin K. Tsai, Tze‐Sian Chan, Yuval Shaked · 2019 · Journal of Clinical Medicine
  20. Cancer-associated fibroblasts (CAFs) in thyroid papillary carcinoma: molecular networks and interactions
    Jeehoon Ham, Bin Wang, Joseph William Po, Amandeep Singh, Navin Niles, Cheok Soon Lee · 2021 · Journal of Clinical Pathology
  21. Androgen Receptor Activation Induces Senescence in Thyroid Cancer Cells
    Anvita Gupta, Michelle A. Carnazza, Melanie Jones, Zbigniew Darżynkiewicz, Dorota H. Halicka, Timmy J. O'Connell, Hong Liang Zhao, Sina Dadafarin, Edward D. Shin, Monica Schwarcz et al. · 2023 · Cancers
  22. Learning about the Importance of Mutation Prevention from Curable Cancers and Benign Tumors
    Gangshi Wang, Lichan Chen, Baofa Yu, Lucas Zellmer, Ningzhi Xu, Dezhong Joshua Liao · 2016 · Journal of Cancer
  23. Tumor suppressor miR‑613 induces cisplatin sensitivity in non‑small cell lung cancer cells by targeting GJA1 Retraction in /10.3892/mmr.2024.13291
    Jianhua Luo, Yan J. Jin, Mengyuan Li, Liyang Dong · 2021 · Molecular Medicine Reports · Retracted
  24. Emerging strategies against tumor-associated fibroblast for improved the penetration of nanoparticle into desmoplastic tumor
    Chen Yunna, Mengru Hu, Wang Fengling, Lei Wang, Chen Weidong · 2021 · European Journal of Pharmaceutics and Biopharmaceutics
  25. Putting the brakes on anticancer therapies: suppression of innate immune pathways by tumor-associated myeloid cells
    Masahisa Jinushi, Hideo Yagita∥, Hironori Yoshiyama, Hideaki Tahara · 2013 · Trends in Molecular Medicine
  26. Extreme low dose of 5-fluorouracil reverses MDR in cancer by sensitizing cancer associated fibroblasts and down-regulating P-gp
    Yan Ma, Yuhua Wang, Zhenghong Xu, Yongjun Wang, John K. Fallon, Feng Liu · 2017 · PLoS ONE
  27. Generation of prostate cancer assembloids modeling the patient-specific tumor microenvironment
    J.-H. Lee, Yun‐Hee Kim, Cheolmin Matthew Lee, Seong Soo Jeon, H.K. Seo, Jong Won Lee, Jungmin Choi, Minyong Kang, Eunjee Kim, Kunyoo Shin · 2025 · PLoS Genetics
  28. Platinum Chemotherapy Induces Lymphangiogenesis in Cancerous and Healthy Tissues That Can be Prevented With Adjuvant Anti-VEGFR3 Therapy
    Alexandra R. Harris, Savieay Esparza, Mohammad Sadegh Azimi, Robert Cornelison, Francesca N. Azar, Danielle C. Llaneza, Maura C. Belanger, Alexander S. Mathew, Svyatoslav Tkachenko, Matthew J. Perez et al. · 2022 · Frontiers in Oncology
  29. Alternative polyadenylation is a determinant of oncogenic Ras function
    Aishwarya Subramanian, Mathew Hall, Huayun Hou, Marat Mufteev, Bin Yu, Kyoko E. Yuki, Haruka Nishimura, Anson Sathaseevan, Benjamin Lant, Beibei Zhai et al. · 2021 · Science Advances
  30. Bone Marrow Adipocytes Contribute to Tumor Microenvironment-Driven Chemoresistance via Sequestration of Doxorubicin
    Jun‐Goo Kwak, Jungwoo Lee · 2023 · Cancers
  31. Site-specific delivery of cisplatin and paclitaxel mediated by liposomes: A promising approach in cancer chemotherapy
    Jianyong Zou · 2023 · Environmental Research
  32. Individual patient oesophageal cancer 3D models for tailored treatment
    John H. Saunders, David Onion, Pamela Collier, Matthew S. Dorrington, Richard H. Argent, Philip A. Clarke, Alexander M. Reece-Smith, Simon L. Parsons, Anna M. Grabowska · 2016 · Oncotarget
  33. In-Depth Characterization of Stromal Cells within the Tumor Microenvironment Yields Novel Therapeutic Targets
    Sebastian Gottfried Walter, Sebastian Scheidt, Robert Nißler, Christopher Gaisendrees, Kourosh Zarghooni, Frank Alexander Schildberg · 2021 · Cancers
  34. Mechanisms of drug resistance in breast cancer liver metastases: Dilemmas and opportunities
    Chunyan Yan, Menglu Zhao, Ya-Nan Wei, Xihe Zhao · 2023 · Molecular Therapy — Oncolytics
  35. A Dual Fluorescent 3-D Multicellular Coculture of Breast Cancer MCF-7 and Fibroblast NIH-3T3 Cells for High Throughput Cancer Drug Screening
    Xin Xin, Shang‐Tian Yang · 2019 · Biochemical Engineering Journal
  36. Identification of potential radiation-responsive biomarkers based on human orthologous genes with possible roles in DNA repair pathways by comparison between Arabidopsis thaliana and homo sapiens
    Lei Zhao, Xinye He, Yuxuan Shang, Chengyu Bao, Ailin Peng, Xiaohua Lei, Pei De Han, Dong Mi, Yeqing Sun · 2019 · The Science of The Total Environment
  37. Modeling chemical effects on breast cancer: the importance of the microenvironment in vitro
    Molly M. Morgan, Linda A. Schuler, Jordan C. Ciciliano, Brian P. Johnson, Elaine T. Alarid, David J. Beebe · 2020 · Integrative Biology
  38. Pyrroloquinoline Quinone Is an Effective Senomorphic Agent to Target the Pro‐Inflammatory Phenotype of Senescent Cells
    Birong Jiang, Hongwei Zhang, Qixia Xu, Zhirui Jiang, Ruikun He, Qiang Fu, Yu Sun · 2025 · Aging Cell
  39. Laser-activated nanoparticles rewire tumor microenvironment enhancing PD-1 blockade and T cell response in cholangiocarcinoma
    Mirko Minini, Giulio Avveduto, Sonia Becharef, Marie Meunier--Thaens, Bouchra Lekbaby, María Pérez-Lanzón, Alice Machado, Thomas Guilbert, Julie Lesieur, Gilles Renault et al. · 2025 · Hepatology
  40. Understanding breast cancer heterogeneity through non-genetic heterogeneity
    Neda Barzgar Barough, Fakhrosadat Sajjadian, Nazila Jalilzadeh, Hajar Shafaei, Kobra Velaei · 2021 · Breast Cancer
  41. The epigenome and the many facets of cancer drug tolerance
    Paul C. Moore, Kurt W. Henderson, Marie Classon · 2023 · Advances in cancer research
  42. The role of host response to chemotherapy: resistance, metastasis and clinical implications
    Abhilash Deo, Jonathan Paul Sleeman, Yuval Shaked · 2023 · Clinical & Experimental Metastasis
  43. Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
    Aurora Gazzillo, Camilla Volponi, Cristiana Soldani, Michela Anna Polidoro, Barbara Franceschini, Ana Lleò, Eduardo Bonavita, Matteo Donadon · 2023 · Biomedicines
  44. Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier
    Kohei Okuyama, Maiko Tsuchiya, Kala Chand Debnath, Shajedul Islam, Souichi Yanamoto · 2025 · Therapeutic Advances in Medical Oncology
  45. Bleomycin analogues preferentially cleave at the transcription start sites of actively transcribed genes in human cells
    Jon Ken Chen, Dong Joo Yang, Ben Shen, Vincent Murray · 2017 · The International Journal of Biochemistry & Cell Biology
  46. Theranostic Nanoparticles and Their Spectrum in Cancer
    Anca Onaciu, Ancuta Maria Jurj, Cristian Silviu Moldovan, Ioana Berindan-Neagoe · 2019 · IntechOpen eBooks
  47. Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin–mediated prostatic tumorigenesis
    Joseph Aldahl, Jiaqi Mi, Ariana Pineda, Won Kyung Kim, Adam W. Olson, Erika Hooker, Yongfeng He, Eun‐Jeong Yu, Viên Lam Le, Dong-Hoon Lee et al. · 2019 · Journal of Biological Chemistry
  48. Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment
    Louis T. Curtis, Susanne Sebens, Hermann B. Frieboes · 2020 · Cancer Immunology Immunotherapy
  49. Possibility of inducing tumor cell senescence during therapy (Review)
    Guohui Wang, Xianliang Cheng, Jingyi Zhang, Yuan Liao, Yinnong Jia, Chen Qing · 2021 · Oncology Letters
  50. Pheophorbide co-encapsulated with Cisplatin in folate-decorated PLGA nanoparticles to treat nasopharyngeal carcinoma: Combination of chemotherapy and photodynamic therapy
    Benzhong Zhou, Yunxia Ma, Longqiao Li, Xianping Shi, Zhitai Chen, Feifeng Wu, Yang Liu, Zesheng Zhang, Shengguo Wang · 2021 · Colloids and Surfaces B Biointerfaces
  51. Non-autonomous consequences of cell death and other perks of being metazoan
    Tin Tin Su · 2015 · Global Medical Genetics
  52. Subpathway-CorSP: Identification of metabolic subpathways via integrating expression correlations and topological features between metabolites and genes of interest within pathways
    Chenchen Feng, Jian Zhang, Xuecang Li, Bo Ai, Junwei Han, Qiuyu Wang, Taiming Wei, Yong Jie Xu, Meng Li, Shang Li et al. · 2016 · Scientific Reports
  53. Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy
    Brian R. Winters, Funda Vakar‐Lopez, Lisha G. Brown, Bruce Montgomery, Roland Seiler, Peter C. Black, Joost L. Boormans, Marc Dall’Era, Elai Davincioni, James Douglas et al. · 2018 · Urologic Oncology Seminars and Original Investigations
  54. Therapy-induced senescence in prostate cancer: mechanisms, therapeutic strategies, and clinical implications
    Luisa F. Guzman Bacca, Julian Brandariz, Francesca Zacchi, Andrea Zivi, Joaquı́n Mateo, David P. Labbé · 2025 · Gene
  55. Wnt Signaling and Therapeutic Resistance in Castration-Resistant Prostate Cancer
    Chandra Kishore, Xiaolin Zi · 2023 · Current Pharmacology Reports
  56. Aging and oral squamous cell carcinoma development: the role of cellular senescence
    Sven Eric Niklander, Pablo Aránguiz, Fernando Faunes, Rene Flores · 2023 · Frontiers in Oral Health
  57. Navigating Tumour Microenvironment and Wnt Signalling Crosstalk: Implications for Advanced Cancer Therapeutics
    Shraddha Shravani Peri, Y. Krithicaa Narayanaa, Therese Deebiga Hubert, Roshini Rajaraman, Frank Arfuso, Sandhya Sundaram, Balasubramanian Archana, Sudha R. Warrier, Arun Dharmarajan, Lakshmi Revathi Perumalsamy · 2023 · Cancers
  58. Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway
    Ziming Zhao, Hongyu Wang, Liao Zhang, Xifan Mei, Jing Hu, Keqiang Huang · 2016 · Anti-Cancer Drugs
  59. Circadian disruption and cancer risk: A new concept of stromal niche
    Hiroto Izumi, Ke‐Yong Wang, Yasuo Morimoto, Yasuyuki Sasaguri, Kimitoshi Kohno · 2013 · International Journal of Oncology
  60. Therapy-Induced Transdifferentiation Promotes Glioma Growth Independent of EGFR Signaling
    Oh, Hwanhee, Hwang, Inah, Jang, Ja-Young, Wu, Lingxiang, Cao, Dongqing, Yao, Jun, Ying, Haoqiang, Li, Jian Yi, Yao, Yu, Hu, Baoli et al. · 2021 · Cancer Research
  61. Sex-Based Differences in the Tumor Microenvironment
    Vincent Wuidar, Lionel Gillot, Isabelle Dias Da Silva, Alizée Lebeau, Anne Gallez, Christel Péqueux · 2021 · Advances in experimental medicine and biology
  62. Comparative transcriptome of normal and cancer-associated fibroblasts
    Apoorva Abikar, M. Mustafa, Radhika Rajiv Athalye, Namratha Nadig, Ninad Tamboli, Vinod Babu, Ramaiah Keshavamurthy, Prathibha Ranganathan · 2024 · BMC Cancer
  63. The roles of cancer stem cells and therapeutic implications in melanoma
    Xiaoli Mu, Yixin Zhou, Yongxin Yu, Mingyi Zhang, Jiyan Liu · 2024 · Frontiers in Immunology
  64. Single-cell sequencing unveils the transcriptomic landscape of castration-resistant prostate cancer-associated fibroblasts and their association with prognosis and immunotherapy response
    Yifeng Qiu, Yuhan Wang, Jiahe Liu, Kai Sun, Baohua Liu, Qi Hou · 2025 · BMC Cancer
  65. Cabozantinib-induced osteoblast secretome promotes survival and migration of metastatic prostate cancer cells in bone
    Kai‐Jie Yu, Jeffrey K. Li, Yu-Chen Lee, Guoyu Yu, Song-Chang Lin, Tianhong Pan, Robert L. Satcher, Mark Anton Titus, Li‐Yuan Yu‐Lee, Wen Hui Weng et al. · 2017 · Oncotarget
  66. IκB-kinase-ε in the tumor microenvironment is essential for the progression of gastric cancer
    Biao Geng, Chen Zhang, Chao Wang, Ying Che, Xianmin Mu, Jinshun Pan, Che Xu, Hu Shi, Jing Yang, Ting Zhao et al. · 2017 · Oncotarget
  67. The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors
    Xinyi Wang, Jing Ai, Hongyan Liu, Peng Xia, Hui Chen, Yi Chen, Yi Su, Aijun Shen, Xun Huang, Jian Ding et al. · 2018 · Molecular Cancer Therapeutics
  68. Inactivation of TFEB and NF-κB by marchantin M alleviates the chemotherapy-driven pro-tumorigenic senescent secretion
    Huanmin Niu, Lilin Qian, Bin Sun, Wenjian Liu, Fang Wang, Qian Wang, Xiaotian Ji, Yanhai Luo, Effat Un Nesa, Hong‐Xiang Lou et al. · 2019 · Acta Pharmaceutica Sinica B
  69. MicroRNAs: Key Regulators in Lung Cancer
    Younes El Founini, Imane Chaoui, Hind Dehbi, Mohammed El Mzibri, Roger Abounader, Fadila Guessous · 2021 · MicroRNA
  70. A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer
    Dimitrios Makrakis, Jonathan Lawrence Wright, Martine P. Roudier, José M. Garcia, Funda Vakar‐Lopez, Michael P. Porter, Yan Wang, Atreya Dash, Daniel Wei Lin, George R. Schade et al. · 2022 · Clinical Genitourinary Cancer
  71. HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer
    Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian et al. · 2023 · Cell Death and Disease
  72. Pharmacological NF‐κB inhibition decreases cisplatin chemoresistance in muscle‐invasive bladder cancer and reduces cisplatin‐induced toxicities.
    Rui M. Gil da Costa, Christine Levesque, Daniella Bianchi-Frias, Payel Chatterjee, Hung‐Ming Lam, Carlos Eduardo Matos dos Santos, Ilsa M. Coleman, Pedro Ferreirinha, Manuel Vilanova, Nazaré Pinto da Cunha et al. · 2023 · Molecular Oncology
  73. Antitumor activity of (R,R’)‐4‐methoxy‐1‐naphthylfenoterol in a rat C6 glioma xenograft model in the mouse
    Michel Bernier, Rajib Kumar Paul, Katina S. S. Dossou, Artur Wnorowski, Anuradha Ramamoorthy, Arnaud Pâris, Ruin Moaddel, Jean‐François Cloix, Irving W. Wainer · 2013 · Pharmacology Research & Perspectives
  74. Clinical significance of immunohistochemically detected extracellular matrix proteins and their spatial distribution in primary cancer
    Beata Čunderlı́ková · 2016 · Critical Reviews in Oncology/Hematology
  75. The ING1a model of rapid cell senescence
    Jessica Bertschmann, Subhash Thalappilly, Karl T. Riabowol · 2018 · Mechanisms of Ageing and Development
  76. Prodrug Nanomedicine Inhibits Chemotherapy-Induced Proliferative Burst by Altering the Deleterious Intercellular Communication
    Yanting Yu, Keqi Xiang, Mingzhi Xu, Yuqiang Li, Jiajunzi Cui, Lanqiong Zhang, Xiaohu Tang, Xianqi Zhu, Lili Qian, Meng Zhang et al. · 2021 · ACS Nano
  77. Friend or Foe: Regulation, Downstream Effectors of RRAD in Cancer
    Zhangyue Sun, Yongkang Li, Xiaolu Tan, Wanyi Liu, Xinglin He, Deyuan Pan, En‐Min Li, Li‐Yan Xu, Lin Long · 2023 · Biomolecules
  78. Bone microenvironment-mediated resistance of cancer cells to bisphosphonates and impact on bone osteocytes/stem cells
    Abeer Abdullah Alasmari, Shih-Chun Lin, Serge Dibart, Erdjan Salih · 2016 · Clinical & Experimental Metastasis
  79. Continuous-flow electrorotation (cROT): improved throughput characterization for dielectric properties of cancer cells
    Kazuma Yoda, Yoshiyasu Ichikawa, Masahiro Motosuke · 2023 · Lab on a Chip
  80. Nanomaterial‐assisted oncolytic bacteria in solid tumor diagnosis and therapeutics
    Xiangdi Zeng, Qi Chen, Tingtao Chen · 2024 · Bioengineering & Translational Medicine
  81. JNK implication in adipocyte-like cell death induced by chemotherapeutic drug cisplatin
    Natalija Krestnikova, Aurimas Stulpinas, Aušra Imbrasaitė, Goda Sinkeviciute, Audronė Valerija Kalvelytė · 2014 · The Journal of Toxicological Sciences
  82. Enhanced DNA repair of bleomycin-induced 3′-phosphoglycolate termini at the transcription start sites of actively transcribed genes in human cells
    Vincent Murray, Jon Ken Chen, Anne M. Galea · 2014 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  83. Adjuvant sorafenib therapy in patients with resected hepatocellular carcinoma: evaluation of predictive factors
    Wei Zhang, Gang Zhao, Kai Wei, Qingxiang Zhang, Weiwei Ma, Qiang Wu, Ti Zhang, Dalu Kong, Qiang Li, Tianqiang Song · 2015 · Medical Oncology
  84. In Utero Exposure to TCDD Alters Wnt Signaling During Mouse Prostate Development: Linking Ventral Prostate Agenesis to Downregulated β-Catenin Signaling
    Andrew J. Schneider, Robert W. Moore, Amanda M. Branam, Lisa L. Abler, Kimberly P. Keil, Vatsal Mehta, Chad M. Vezina, Richard E. Peterson · 2014 · Toxicological Sciences
  85. Interaction between cancer cells and cancer-associated fibroblasts after cisplatin treatment promotes cancer cell regrowth
    Shoshi Hisamitsu, Tomoyuki Miyashita, Hiroko Hashimoto, Shinya Neri, Masato Sugano, Hiroshi Nakamura, Shota Yamazaki, Atsushi Ochiai, Kōichi Goto, Masahiro Tsuboi et al. · 2019 · Human Cell
  86. Altered BMP2/4 Signaling in Stem Cells and Their Niche: Different Cancers but Similar Mechanisms, the Example of Myeloid Leukemia and Breast Cancer
    Boris Guyot, Sylvain Lefort, Thibault Voeltzel, Eve‐Isabelle Pécheur, Véronique Maguer‐Satta · 2022 · Frontiers in Cell and Developmental Biology
  87. Paracrine Wnt signaling is necessary for prostate epithelial proliferation
    Xing Wei, Martine P. Roudier, Oh‐Joon Kwon, Justin Daho Lee, Kevin Kong, Ruth F. Dumpit, Lawrence D. True, Colm M. Morrissey, Daniel Wei Lin, Peter S. Nelson et al. · 2022 · The Prostate
  88. Tetrandrine for Targeting Therapy Resistance in Cancer
    Ellen Nogueira Lima, Santosh Lamichhane, Pramod Bahadur K. C, Elisa S. Ferreira, Sweaty Koul, Hari K. Koul · 2024 · Current Topics in Medicinal Chemistry
  89. CAF-derived exosomal miR-196b-5p after androgen deprivation therapy promotes epithelial-mesenchymal transition in prostate cancer cells through HOXC8/NF-κB signaling pathway
    Xiaodong Song, Tiewen Li, Wenhao Zhou, Chengling Feng, Zeng Zhou, Yuanming Chen, Li Deng, Lei Chen, Jing Zhao, Yu Zhang et al. · 2025 · Biology Direct
  90. Microphysiological Systems in Cancer Research: Advancing Immunotherapy through Tumor Microenvironment‐Integrated Organ‐On‐Chip Models
    Fabiana Moresi, Francesco Noto, Jyothsna Vasudevan, Xavier Bisteau, Giulia Adriani, Andrea Pavesi · 2025 · Advanced Therapeutics
  91. Ultrasound-Driven Cu-Nanobots for Tumor Deep Penetration and Induction of Cuproptosis in Prostate Cancer Therapy
    Jiaxi Xu, Mingchen Lv, Wei Hu, Ran Chen, Shangpeng Liu, Min Sun, Jianzhong Du, Zhen Fan · 2025 · ACS Applied Materials & Interfaces
  92. KDM4 Orchestrates Epigenomic Remodeling of Senescent Cells and Potentiates the Senescence‐Associated Secretory Phenotype
    Boyi Zhang, Qilai Long, Shanshan Wu, Qixia Xu, Shuling Song, Liu Han, Min Qian, Xiaohui Ren, Hanxin Liu, Jing Hua Jiang et al. · 2025 · Aging Cell
  93. Alteration of Proteotranscriptomic Landscape Reveals the Transcriptional Regulatory Circuits Controlling Key-Signaling Pathways and Metabolic Reprogramming During Tumor Evolution
    Geoffroy Andrieux, Sajib Chakraborty, Tonmoy Das, Melanie Boerries · 2020 · Frontiers in Cell and Developmental Biology
  94. TCF12 regulates exosome release from epirubicin-treated CAFs to promote ER+ breast cancer cell chemoresistance
    Yuxiang Qiu, Xing Wang, Yan Sun, Yan-e Du, Guobing Yin, Haojun Luo, Siyang Wen, Lei Lang, Manran Liu, Xi Tang · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  95. The ‘omics of obesity in B-cell acute lymphoblastic leukemia
    Delaney K. Geitgey, Mi‐Young Lee, Kirsten A. Cottrill, Maya Jaffe, William Pilcher, Swati Sharma Bhasin, Jessica M. Randall, Anthony J Ross, Michelle Salemi, Marisol Castillo‐Castrejón et al. · 2023 · JNCI Monographs
  96. TH1 cytokines induce senescence in AML
    Hisayoshi Hashimoto, Derya Güngör, Naomi Krickeberg, Johanna Schmitt, Larissa Doll, Marina Schmidt, Sabine Schleicher, Elvira Criado-Moronati, Karin Schilbach · 2022 · Leukemia Research
  97. Circulating metabolites in the early stage of breast cancer were not related to cancer stage or subtypes but associated with ki67 level. Promising statistical discrimination from controls
    Eva Baranovičová, Peter Račay, Pavol Žúbor, Marek Smolár, Eva Kúdelová, Erika Halášová, Dana Dvorská, Zuzana Daňková · 2022 · Molecular and Cellular Probes
  98. A Theranostic Nanoprobe for Hypoxia Imaging and Photodynamic Tumor Therapy
    Jing Hao Fan, Guiling Fan, Ping Yuan, Fu‐An Deng, Lingshan Liu, Xiang Zhou, Xi Yong Yu, Hong Bo Cheng, Shiying Li · 2019 · Frontiers in Chemistry
  99. Mechanisms of Cancer Resistance to Various Therapies
    Asiya Batool, Waseem Rashid, Kaneez Fatima, Sameer Ullah Khan · 2024 · Springer eBooks
  100. Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilities
    Frida Rantanen, Astrid Murumägi, Mariliina Arjama, Katja E. Välimäki, Elina Multamäki, Tuomas K. Mirtti, Antti Sakari Rannikko, Teijo S. Pellinen, Daniela Ungureanu, Olli Kallioniemi · 2025 · Cell Death Discovery